Claudia Elizabeth Imperiali

Claudia Elizabeth Imperiali

Auto-generated profile, based on publicly available information

Claudia Elizabeth Imperiali

Laboratori Clínic Territorial Metropolitana Sud-Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in Biochemia Medica
Verified
Journal Article
Open access
PDF file
CIClaudia E. Imperiali
Claudia E. Imperiali
AAAriadna Arbiol-Roca
Ariadna Arbiol-Roca
LSLourdes Sanchez-Navarro
Lourdes Sanchez-Navarro
MDMacarena Dastis-Arias
Macarena Dastis-Arias
JLJuan C. Lopez-Delgado
Juan C. Lopez-Delgado
DDDolors Dot-Bach
Dolors Dot-Bach
Reference interval for immature platelet fraction on Sysmex XN haematology analyser in adult population

1 November 2020 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
AAAriadna Arbiol-Roca
Ariadna Arbiol-Roca
PHPh.D.
Ph.D.
CIClaudia Elizabeth Imperiali
Claudia Elizabeth Imperiali
DDDolors Dot-Bach
Dolors Dot-Bach
JVJosé Valero-Politi
José Valero-Politi
MDMacarena Dastis-Arias
Macarena Dastis-Arias
Ariadna Arbiol-Roca, Ph.D., Claudia Elizabeth Imperiali, Ph.D., Dolors Dot-Bach, Ph.D., José Valero-Politi, Ph.D., and Macarena Dastis-Arias, Ph.D.. Ann Lab Med 2020;40:448-56. https://doi.org/10.3343/alm.2020.40.6.448

15 November 2019 in Journal of Clinical Pathology
Verified
Journal Article
Closed access
PDF file
CIClaudia Elizabeth Imperiali
Claudia Elizabeth Imperiali
JLJuan Carlos Lopez-Delgado
Juan Carlos Lopez-Delgado
MDMacarena Dastis-Arias
Macarena Dastis-Arias
LSLourdes Sanchez-Navarro
Lourdes Sanchez-Navarro
Aims Cardiac surgery (CS) can induce an inflammatory response (IR) that is associated with poorer outcomes. Immature platelets are among the factors that may be associated with IR development. We aimed to evaluate whether immature platelet fraction (IPF) could be a predictive biomarker for IR and whether IPF could improve the prognosis assessment of IR for Acute Physiologic and Chronic Health Evaluation (APACHE II) and Sequential Organ Failure Assessment (SOFA) following CS. Methods Three-hundred and twenty-seven (327) patients who underwent CS were enrolled during the study period. IR was defined according to the need for vasopressor support (>48 hours). Perioperative variables and outcomes were registered in our database. IPF was measured immediately following CS and at 24 hours by Sysmex XN analyzer and the difference between both measurements (ΔIPF) was calculated. To assess the relationship between ΔIPF and IR, univariate and multivariate logistic regression were performed. To analyse the additive value of ΔIPF in APACHE II and SOFA scores in predicting IR, an area under the receiver operating characteristic (AUROC) curve was calculated. Results Among 327 patients included, 60 patients (18.3%) developed IR. Multivariate analysis showed ΔIPF was significantly associated with IR (OR: 1.26; 95% CI: 1.01 to 1.56; p=0.038). The combination of ΔIPF with scores improved the AUROC for IR prediction: 0.629 vs 0.728 (p=0.010) for APACHE II and 0.676 vs 0.715 (p=0.106) for SOFA. Conclusion These findings suggested that ΔIPF may be a useful and low-cost biomarker for the early identification of patients at risk of IR development.

25 July 2020 in Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
Verified
Journal Article
Open access
PDF file
CIClaudia E. Imperiali
Claudia E. Imperiali
Juan Carlos Lopez-DelgadoJuan Carlos Lopez-Delgado
Juan Carlos Lopez-Delgado
MDMacarena Dastis-Arias
Macarena Dastis-Arias
LSLourdes Sanchez-Navarro
Lourdes Sanchez-Navarro
Objectives: The postoperative period of cardiac surgery (CS) is associated with the development of major adverse cardiovascular events (MACEs). However, the evaluation of MACE after CS by means of biomarkers is poorly developed. We aimed to evaluate postoperative biomarkers that could be associated with MACE.Methods: Two Hundred and ten patients who underwent CS were enrolled during the study period. The diagnosis of MACE was defined as the presence of at least one of the following complications: acute myocardial infarction, heart failure, stroke presented during intensive care unit (ICU) stay, and 30-day mortality after CS. High-sensitive troponin T (hs-TnT), C-reactive protein, procalcitonin, interleukin-6, and immature platelet fraction (IPF) were measured on ICU admission and after 24 h. The difference between both measurements (Δ) was calculated to assess their association with MACE. Early infected patients (n=13) after CS were excluded from final analysis.Results: The most frequent surgery was single-valve surgery (n=83; 38%), followed by coronary artery bypass graft (n=72; 34%). Postoperative MACE was diagnosed in 31 (14.8%) patients. Biomarker dynamics showed elevated values at 24 h compared with those at ICU admission in patients with MACE versus no-MACE. Multivariate analysis showed that ΔIPF (OR: 1.47; 95% CI: 1.110–1.960; p=0.008) and Δhs-TnT (OR: 1.001; 95% CI: 1.0002–1.001; p=0.008) were independently associated with MACE.Conclusions: These findings suggest that postoperative ΔIPF and Δhs-TnT may be useful biomarkers for the identification of patients at risk of MACE development.

11 November 2020 in Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
Verified
Journal Article
Open access
PDF file
CIClaudia E. Imperiali
Claudia E. Imperiali
Juan Carlos Lopez-DelgadoJuan Carlos Lopez-Delgado
Juan Carlos Lopez-Delgado
MDMacarena Dastis-Arias
Macarena Dastis-Arias
LSLourdes Sanchez-Navarro
Lourdes Sanchez-Navarro
Resumen: Objetivos: Aunque los eventos cardiovasculares adversos mayores (MACE) son frecuentes en el postoperatorio de la cirugía cardíaca (CC), no se suele evaluar el riesgo de desarrollarlos. Analizamos una serie de biomarcadores postoperatorios potencialmente relacionados con el desarrollo de MACE durante el postoperatorio de CC.Métodos: Se incluyeron 210 pacientes de CC. Se consideraron MACE el infarto agudo de miocardio, fallo cardíaco, ictus durante el ingreso en la unidad de cuidados intensivos, y mortalidad a los 30 días tras la CC. Se midieron la troponina T de alta sensibilidad (hs-TnT), proteína C reactiva (PCR), procalcitonina (PCT), interleucina 6 (IL-6) en plasma y la fracción de plaquetas inmaduras (IPF) en sangre al ingreso en la UCI y a las 24 h. Se calculó la diferencia entre ambas medidas (Δ) para evaluar la relación entre estos biomarcadores y MACE. Los pacientes con infección inmediata tras la CC (n=13) fueron excluidos del análisis final.Resultados: Las intervenciones más frecuentes fueron la cirugía univalvular (n=83; 38%) y la cirugía de revascularización coronaria (n=72; 34%). Se diagnosticaron MACE postoperatorios en 31 (14.8%) pacientes. Los pacientes con MACE mostraron una elevación de biomarcadores a las 24 h con respecto al ingreso en la UCI. Se observó una relación independiente entre ΔIPF (OR: 1.47; 95% CI: 1.110–1.960; p=0.008) y Δhs-TnT (OR: 1.001; 95% CI: 1.0002–1.001; p=0.008) y los MACE.Conclusiones: Las concentraciones postoperatorias de ΔIPF y Δhs-TnT pueden ser útiles para identificar a pacientes con riesgo de desarrollar MACE.

1 September 2021 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
AAAriadna Arbiol-Roca
Ariadna Arbiol-Roca
CIClaudia Elizabeth Imperiali
Claudia Elizabeth Imperiali
Ariadna Arbiol-Roca, Ph.D. and Claudia Elizabeth Imperiali, Ph.D.. Ann Lab Med 2021;41:504-5. https://doi.org/10.3343/alm.2021.41.5.504